US hospital systems validate the safety, clinical utility, and robustness of newly FDA-approved devices, 510(k) cleared, before adopting them into clinical practice. This work occurs alongside evaluating how to integrate the medical device into the hospital system’s diagnostic paradigms, including in relation to quality improvement programs. Companies can have a role but there are 415 US hospital systems (comprising ~5,000 hospitals), and each has a bespoke process and ever-changing set of
Read More
Abbott
American Diabetes Association Launches Amputation Prevention Alliance
What You Should Know:
- The American Diabetes Association® announced a new initiative designed to address the urgent public health challenge of preventable amputation called the Amputation Prevention Alliance. Over 135,000 amputations occur every year in the United States, with the majority of those procedures being preventable, but due to challenges in accessing quality care, patients are forced into unnecessary amputations and even death.
- The Amputation
Read More
Size Matters When it Comes to Choosing The Right Stent
It doesn’t take long for kids to figure out that people come in all different shapes and sizes and that what differentiates us from one another is what makes us unique. And while we are told from a young age that we are all the same inside—that we all see, smell, taste, touch and hear the same as one another—there are nuances to this that become apparent as we age.Our vasculature is a good case in point. While our arteries all carry blood to and from the heart, they are not all the same size.
Read More
Abbott Launches New AI-Powered Coronary Imaging Platform in Europe
What You Should Know:
- Abbott announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization.
- The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure
Read More
Abbott to Launch App to Track and Report Pain Relief in Chronic Pain Patients
What You Should Know:
- Abbott launches new app, NeuroSphere myPath that will
allow patients to record their pain relief during the device trial period with
spinal cord stimulation or dorsal root ganglion therapy, simplify reporting
outcomes and connect patients to physicians who have real-time access to this
data
- NeuroSphere myPath will be available in the Apple App
Store in the coming weeks and will be compatible with the latest iOS operating
system
Abbott announced the
upcoming
Read More
Why Some COVID-19 Testing Protocols Aren’t What You Think
While countries around the world continue to flounder with regards to COVID-19 testing, everyone is wondering how national governments could get things so horribly wrong. It’s true that governments have acted incompetently, leaders can make poor judgment calls, and optimistic testing targets are rarely achieved.
But the claims of various ambitious big pharma companies—about their ability to deliver on capacity and accuracy alike—have created a smokescreen for decision-makers, one that has
Read More
Digital Diabetes Market to Reach $1.5B by 2024, Research Finds
What You Should Know:
- The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance.
- The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.
- Digital diabetes solutions have disrupted the
Read More
White House Coronavrius Task Force Doubles Down on Rapid Testing Strategy
What You Should Know:
- White house coronavirus task force doubles down on rapid testing strategy to fight the coronavirus as some states say they don’t have the supplies to comply with the federal government’s advice.
- This article was originally published by the Center for Public Integrity, a nonprofit investigative news organization based in Washington, D.C.
The White House coronavirus task force is doubling down on part of its strategy for halting the spread of the virus:
Read More
How Data-Driven Technology Holds The Promise of Better Outcomes for Vascular Patients
Abbott recently released global research on vascular patient care, designed to shine a light on the vascular patient journey. The report called “Beyond Intervention” uncovers the universal challenges faced by physicians who deliver vascular care, their patients, and the hospital administrators who support them. It also explores how the right use of technology and data could potentially enable more precise diagnoses and better treatment strategies to ensure the best possible patient
Read More
Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe
What You Should Know:
- Abbott has received CE Mark (European approval)
for its next-generation FreeStyle Libre 3 system for people with diabetes.
- FreeStyle Libre 3 is the latest advancement from
Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest
continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies)
and a more environmentally sustainable system design.
Abbott, the worldwide
leader in continuous glucose
Read More
